LUVIT D3 Cholecalciferolum Oily Solution 4000 IU/ml for the Prophylaxis

AMZV

What is LuVit D3 and when is it used?

LuVit D3 is an oily solution with cholecalciferol (vitamin D3).

Vitamin D₃ can normally be produced in the skin under the influence of sunlight.

Vitamin D₃ is necessary and indispensable for calcium absorption from food for normal bone formation.

If there is insufficient exposure to the sun, insufficient intake of vitamin D₃-enriched foods and if there is an increased need for vitamin D₃ during growth, pregnancy and lactation, the body must also be offered this vitamin.

LuVit D3 is used for the following diseases:

-prevention of softening of the bones in the child (rickets);

-prevention of osteoporosis deviation in adults (osteomalacia);

-Preventive doses: strong growth phases, pregnancy and lactation.

When should LuVit D3 not be used?

-Only take the dose prescribed by your doctor for the specified period of time.

-Avoid taking excessive vitamin D doses for months or years, especially if you are taking calcium and/or vitaminized nutrients at the same time average (e.g. bottle preparations).

-Vitamin D preparations must not be used in conditions with an increased calcium content in the blood or urine or in excretion disorders of the kidneys.

When is caution required when taking LuVit D3?

All D-vitamins are harmful if they are taken in excessive doses (more than 1000-3000 lU per kg body weight).

In the event of calcium disorders change, kidney disease and heart disease require special care. In these cases, you should consult your doctor.

Inform your doctor, pharmacist or druggist if you suffer from other illnesses, have allergies or are taking other medicines (even those you bought yourself!) or use them externally!

Can LuVit D3 be taken during pregnancy or while breastfeeding?

Based on previous experience, with more than as intended Application no known risk for the child. However, systematic scientific investigations have never been carried out. As a precaution, you should avoid taking medicines during pregnancy and breastfeeding, or ask your doctor, pharmacist or druggist for advice.

How do you use LuVit D3?

To prevent rickets

Your doctor usually prescribes 0.1 ml (=400 IU) per day, in premature babies 0.1 - 0.2 ml (=400 - 800 IU) daily until the end of the first year of life.

Possibly in the second year of life during the months with little sun 0.1 ml (=400 IU) should also be administered.

Pregnancy

Daily 0.1 ml (= 400 IU) from the 6th to the 9th Month of pregnancy.

Breast feeding

Daily 0.1 ml (= 400 IU).

Application of the solution

If daily administration of the oral solution is not feasible, the doctor must be consulted.

Follow the instructions given in the package insert or by the doctor or the dosage prescribed by the doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can LuVit D3 have?

With the prescribed dosage, no side effects are to be expected.

If you notice any side effects that are not described hereshould inform your doctor or pharmacist.

What else needs to be considered?

The medicinal product may only be used up to the date marked «EXP» on the container.

Store in the original packaging at room temperature (15-25 °C) and protected from light.

Keep out of the reach of children.

Shelf life 3 months after opening.

Cloudy Do not use the solution.

Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for professionals.

What does LuVit D3 contain?

1 ml contains:

Active ingredient: cholecalciferol 4000 international units (IU) and excipients.

Authorization number

66124 (Swissmedic)

Where can you get LuVit D3? What packs are available?

In pharmacies and drugstores, without a doctor's prescription.

Packs of 10 ml with a dosing pipette, graduated in 0.05/0.1 ml.

Packs of 20 ml with a dosing pipette, graduated in 0.10/0.15/0.20 ml

Authorization holder

Drossapharm AG, 4002 Basel.

This leaflet was last checked by the drug authority (Swissmedic) in September 2013.